Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen-Positron Emission Tomography era

IJU Case Rep. 2023 Aug 11;6(6):337-340. doi: 10.1002/iju5.12614. eCollection 2023 Nov.

Abstract

Introduction: The absence of prostate cancer on final surgical pathology after biopsy-proven prostate cancer is a rare finding.

Case presentation: Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound-guided biopsy in a man who underwent both magnetic resonance imaging and 18F-PSMA-1007 Positron Emission Tomography prior to radical prostatectomy.

Conclusion: pT0 prostate cancer is rare. The use of novel imaging modalities may help in the workup of prostate cancer.

Keywords: PSMA PET; multiparametric MRI; prostate cancer; vanishing cancer.

Publication types

  • Case Reports